What is Medicines Management?

Medicines management is an evidence-based approach to prescribing which balances the safety, tolerability, effectiveness and cost of treatments. The aim of the medicines management team is to ensure that our patients receive better, safer and more convenient care.

Medicines management includes:

  • Giving unbiased information about medicines and treatments and where they should be used in care pathways
  • Supporting practitioners and patients to make best use of medicines
  • Minimising the harm caused by medicines
  • Developing local guidelines to optimise the management of conditions
  • Working with service providers (including hospitals, community teams, hospitals, hospices, mental health, community pharmacists and GP practices) to provide safe and effective access to medicines from the most appropriate service.
  • Encouraging appropriate use of antimicrobials to reduce the risk of resistance.
  • Advising on the use of new drugs and new research.

For more information, visit the “Who are the Medicines Management team?

Medicines Management

COVID 19 - Patients

COVID 19 - Clinicians

Useful Covid 19 Resources:

Oxford Astra Zeneca 

Pfizer BioNtech

Patient Group Direction (PGD) Summary for Covid 19 Vaccines

NHSE Standard Operating Procedure (SOP) - Covid 19 local vaccine services deployment in community setting

Gov UK - Covid 19 Vaccaniation Programme - Protocols and PGDs

Letter from Chief Medical Officers re UK Covid 19 Vaccination Programme – Dec 2020

Optimising the Covid 19 vaccination programme for maximum short-term impact

Green Book – Covid 19

Guidance for Care Homes on the use of Vitamin D supplements obtained by the DHSC




Covid 19 Vaccine Pharmacy Communications Reference Guide 

Rescue Pack Letter

Rescue Pack for COPD and Asthma

COVID related professional advice

Remote Outpatients Clinics - Medicine Supply

Responsibility for Prescribing

Amber Drugs - Covid 19

NHS Volunteers Responders Information for Primary Care Professionals

How patients can order repeat prescriptions electronically

Ibuprofen and Coronavirus (COVID 19)

Police Pharmacy Advice - COVID

Shared Care Drugs Monitoring during COVID 19

Position statement for prescribing for patients abroad during Coronavirus outbreak

Ramadan Rapid Review Recommendations - Risk Table

Lithium Guidance COVID 19

Access to Palliative Care Drugs

Access to EOL Drugs in Primary Care during COVID 19

Webinar for the Essex arrangements for accessing EOL Medicines and your role in the re-use of medicines in care homes:


Prescription Management during COVID 19

Hospitals Group Anticoagulation Clinics




Chapter 1 - Gastro-intestinal system

Chapter 2 - Cardiovascular system

Chapter 3 - Respiratory system

Chapter 4 - Nervous System

Chapter 5 - Infection

Chapter 6 - Endocrine system

Chapter 7 - Genito-Urinary System

Chapter 8 - Malignant disease

Chapter 9 - Nutrition and blood

Chapter 10 - Musculoskeletal System

Chapter 11 - Eye

Chapter 12 - Ear, Nose and Oropharynx

Chapter 13 - Skin

End of Life Formulary

Wound Care Formulary

Traffic light list for prescribing

Position Statements

7 Day Prescriptions

Alprostadil Cream


Cannabis Products MSEMOC Position Statement

Camouflage Creams

Chronic Fatigue Syndrome (CFS) or myalgic encephalomyelitis (ME)

Compression Hosiery

Controlled Drugs on repeat Templates

Co-proxamol is not supported for acute of chronic pain


Dental Preparations MSEMOC Position Statement


Doxazosin modified release

Dry Eye Symdrome

Dupilumab for treating Chronic Rhinosinustis with Nasal Polyps MSEMOC Position Statement


Emollients Prescribing Guidance

Eye Vitamins


Fentanyl Immediate Release Preparation MSEMOC Position Statement

Fungal Nail Infection

Glucosamine for osteoarthritis

Good practice for paracetamol prescribing

Heel Balms

Homeopathic Remedies

Hepatitis B

Herbal Treatments

Immediate Release fentanyl

Infantile Colic

Ketamine for chronic pain

Length of repeat prescription supply

Lidocaine plasters

Liothyronine MSEMOC Position Statement

Low dose naltexone for the treatment of Multiple Sclerosis

Medical Devices

Medicines that are Available for Purchase Over the Counter (Self Care)


Mexiletine (Namuscla) for the symptomatic treatment of myontonia in adults


Molludab for molluscum contagiosum

Multivitamins post bariatric surgery MSEMOC Position Statement

Omega 3 fatty acids

Oxycodone and Naloxone MSEMOC Position Statement

PDE5 Inhibitors for the Treatment of Erectile Dysfunction

Perindopril arginine

Pigmanorm cream for the treatment of melasma



Silicone Sheets and Gels

Sodium hyaluronate for osteoarthritis

Sunscreen Preparations

Therapeutic Clothing

Tramadol and paracetamol MSEMOC Position Statement

Transfer of Prescriptions from Private to NHS

Travel Advice


Prescribing for Patients abroad during Coronavirus

Vitamin B Complex

Vitamin D for supplemention insufficiency and maintenance doses MSEMOC Position Statement

Shared Care Guidelines

Prescribing Incentive Scheme

Prescribing Newsletters

Patient Information

Patient Letters

Practice Policies/Resources


National Medicine Shortages

NHSE Consultation


Latest Tweets